Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

808.61 +1.42 (+0.18%)
Official Closing Price Updated: 7:00 PM EDT, Jun 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
3 Trades Members of Congress Are Making Right Now
Knowing what Congressional leaders are buying can give investors insight into future legislation that could benefit these companies 
Via MarketBeat
Topics ETFs Government
Exposures Political
Investing for the Long Term: 1 Unstoppable Vanguard ETF to Buy and Hold Forever
Via The Motley Fool
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
2 Growth Stocks to Own for Decades and 1 to Steer Clear Of
Growth is oxygen. But when it evaporates, the consequences can be extreme - ask anyone who bought Cisco in the Dot-Com Bubble (Nvidia?) or newer investors who lived through the 2020 to 2022 COVID... 
Via StockStory
Exposures COVID-19
5 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Huge News for Eli Lilly Stock Investors!
Via The Motley Fool
Hims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s Dull
Truist noted on Thursday that the $200/month price point is "highly attractive compared to other price points in the market," including Hims & Hers' compounded Semaglutide, Wegovy, and Liraglutide... 
Via Stocktwits
Better Weight Loss Stock: Amgen or Viking Therapeutics?
Via The Motley Fool
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
Via The Motley Fool
Is the Vanguard Dividend Appreciation ETF a Buy Now?
Via The Motley Fool
Topics ETFs
Wegovy, Zepbound Just Got Cheaper: Cigna Sets $200 Monthly Limit For Weight-Loss Drug Users
Cigna’s Evernorth has reached agreements with Eli Lilly and Novo Nordisk to reduce prices for GLP-1 weight-loss drugs Wegovy and Zepbound 
Via Stocktwits
Eli Lilly Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Best Healthcare Stocks: Eli Lilly vs. Novo Nordisk
Via The Motley Fool
Trump's $6 Trillion Investment Deals Face Reality Check: Only A Fraction May Reach The Real Economy
Despite $6 trillion in promised investments under Trump, Goldman Sachs estimates only $30B–$135B will meaningfully impact U.S. GDP. 
Via Benzinga
Topics Government
Exposures Political
Marjorie Taylor Greene Goes Shopping For Tesla, Netflix, UnitedHealth And More: 19 Stocks The Congresswoman Bought
Marjorie Taylor Greene disclosing buying 19 different stocks in a new filing. The buys come less than two weeks after the purchase of 50 different stocks. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Apple, Nvidia, GM: CEOs Are Talking About Being American-Made Again
US companies are reshoring manufacturing operations & investing billions in the country, led by Apple & Nvidia for tech, J&J & Eli Lilly for healthcare, Anheuser-Busch for beer, & Cra-Z-Art for toys.... 
Via Benzinga
Great News for Eli Lilly Stock Investors!
Via The Motley Fool
Ireland: America’s Gateway to Europe – The $2 Trillion Investment Story
Via AB Newswire
The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants
is it the end of the diabetes industry? Here's a small cap that could upend the business models of pharma giants... 
Via Benzinga
23andMe Finds A Big Biotech Buyer In $256 Million Bankruptcy Auction
The acquirer says it will continue 23andMe's consumer genome testing services. It acquired a number of programs, including the biobank. 
Via Investor's Business Daily
Topics Bankruptcy
Exposures Financial Legal
The Nasdaq Just Soared 30% From Its 2025 Low: 3 Vanguard ETFs to Buy Now
Via The Motley Fool
Topics ETFs Economy Stocks
Exposures Economy Tariff US Equities
Why Is Eli Lilly Stock Crashing and Is It a Buying Opportunity?
Via The Motley Fool
Got $1,000 to Invest? Buy This Top Vanguard ETF and Never Look Back.
Via The Motley Fool
Topics ETFs
MarketBeat Week in Review – 05/12 - 05/16
Stocks had a strong week on a potential U.S.-China trade deal and cooler inflation data, but volatility may remain as investors shift focus to tax cuts 
Via MarketBeat
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence Economy Interest Rates
Eli Lilly Pulls Ahead Of Novo In Obesity Drug Gold Rush As New Players Crowd In
Eli Lilly has steadily gained market share against Novo's Wegovy which finds itself catching up. 
Via Talk Markets
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Discover which S&P500 stocks are making waves on Friday.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session. 
Via Chartmill
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Stocks That Will Profit From Trump's Drug Price Cut
Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big pharma may be hit hardest. 
Via Benzinga
Topics Government
Exposures Political
Stocks Fight For Fifth Day Of Gains, Dollar Rebounds As Inflation Fears Go Haywire: What's Driving Markets Friday?
Wall Street fought for a fifth consecutive day of gains on Friday, with major indexes edging slightly higher by midday in New York as investors continued to digest the week's significant trade... 
Via Benzinga
Topics Economy
Exposures Interest Rates
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.